C01EB15 • trimetazidine • Cardiovascular system | Other cardiac preparations
Trimetazidine is a medication primarily used for the treatment of angina pectoris (chest pain caused by reduced blood flow to the heart) and other ischemic heart conditions. It works by optimizing the energy metabolism of myocardial cells (heart cells) under conditions of reduced oxygen supply, thereby protecting the heart from the effects of ischemia.
Trimetazidine is used to reduce the frequency and severity of angina episodes, improving exercise tolerance and the quality of life for patients. It may also be used as an adjunct therapy in other conditions involving tissue ischemia.
Side effects are generally rare but may include dizziness, nausea, headaches, or, in very rare cases, tremors or muscle stiffness. It is important to take the medication as prescribed by a doctor and avoid abrupt discontinuation of treatment.
Substance: trimetazidine
Date of last drug list: 01-01-2019
Commercial code: W56691011
Concentration: 35mg
Pharmaceutical form: prolonged-release tablets
Quantity: 60
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.